Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Matthew Cooper is a Professor of Surgery at Georgetown School of Medicine and the Director of Kidney and Pancreas Transplantation at the Medstar Georgetown Transplant Institute (MGTI).
After receiving his medical degree from the Georgetown University School of Medicine in 1994, Dr Cooper completed his general surgery training at the Medical College of Wisconsin followed by a fellowship in multi-organ abdominal transplantation in 2002 at the Johns Hopkins Hospital in Baltimore, MD. He joined the transplant faculty at the Johns Hopkins Hospital upon completion of his training and was appointed Surgical Director of Kidney Transplantation and Clinical Research in 2003. Dr Cooper joined the University of Maryland in 2005 directing the kidney transplant and clinical research program until 2012 following which he assumed his current role in Washington, DC.
Dr Cooper trained with the pioneers of the laparoscopic donor nephrectomy procedure and seeks new opportunities for living donation through innovation and by removing the disincentives for those considering donation while promoting the safety and long-term care of live organ donors. His clinical interests included kidney and pancreas transplantation; particularly the use of marginal organs and has recently chaired a NKF sponsored Task Force to decrease kidney allograft discards which has led to several exciting projects to potentially bring more patients an opportunity for kidney transplantation. Dr Cooper is involved in several ongoing clinical research projects primarily with an interest in immunosuppression minimization and amelioration of delayed graft function in kidney allografts following ischemic reperfusion injury. He has authored over 130 peer-reviewed manuscripts, 220 abstracts and 6 book chapters. He is regularly invited to speak on a variety of transplant-related topics both nationally and internationally.
Dr Cooper is involved in transplantation activities both locally in the District and on a national basis. He is a member of the National and DC Board of Directors for the NKF and a member of the NKF's National Transplant Task Force and Public Policy Committee. He has served as the chairman of the United Network of Organ Sharing's Living Donor Committee and currently acts as the Councillor for UNOS’ Region 2. He is a current board member for the National Kidney Registry, the American Foundation for Donation and Transplantation, the International Pancreas and Islet Cell Transplant Association, Donate Life America and the local OPO – Washington Regional Transplant Community. Dr Cooper is the immediate Past Chairman for the American Transplant Congress and a member of the planning committee for upcoming International Congress of the Transplantation Society in Seoul.
Dr Emily Blodget, MD, MPH received her undergraduate degree in Human Biology at Stanford University. She then received her Masters in Public Health in Boston University before pursuing her medical degree in Ireland at the University College Cork. After completing her internship in Ireland, she completed her Internal Medicine Residency at the Mt. Sinai Elmhurst Hospital Center in Queens New York. She moved back to California for a fellowship in Infectious Diseases at Los Angeles County/University of Southern California Medical Center where she developed an interest in transplant Infectious Diseases. She became faculty in the Division of Infectious Diseases in 2010 where she practices transplant Infectious Diseases. She has a special interest in resistant bacteria in solid organ transplant recipients.